Progressing Drug Therapies to Market: The Criticality of Analytical Testing Robustness

IND enabling

Rigorous, effective analytical testing is key in the drug development lifecycle. Because this testing is used to verify control of drug chemistry, it can help identify barriers that prevent movement to the next phase in the development process. That’s why it’s critical to have efficient, accurate and high-quality analytical support for your testing requirements.

Partnering with the right CDMO can mean the difference between quality results and potential setbacks for your program. Watch our webinar to hear Cambrex experts discuss:

  • Early-phase analytical support for IND submission
  • Transitioning methods from early-phase to late-phase
  • Case studies highlighting how Cambrex applies analytical testing expertise to help progress clients’ drug therapies